Pharmacoepidemiology and Pharmaco-Economics

Recent advances in DNA repair are DNA interstrand cross-links (ICLs) are lesions caused by a variety of endogenous metabolites, ecological exposures, and cancer chemotherapeutic agents that have two reactive groups.

An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.

Pharmaco economics compares the value of one pharmaceutical drug or drug therapy to another.The general feature of these diverse lesions is that two nucleotides on opposite strands are joined covalently.Understanding the specificity of mutagens in bacteria has led to the direct implication of certain environmental mutagens in the causation of human cancers.

An overview of biopharmaceutical single-use technologies, which aid the manufacturing process in overcoming such complex issues as sterilization and critical manufacturing parameters. Analyses of global market trends, with data from 2013 and 2014, and projections of CAGRs through 2019.

  • Molecular epidemiology and its biomarkers
  • Molecular pathological epidemiology
  • Pharmacovigilance and post marketing surveillance
  • Adverse event reporting system

Related Conference of Pharmacoepidemiology and Pharmaco-Economics

Pharmacoepidemiology and Pharmaco-Economics Conference Speakers